A new study done by Israeli scientists has shown that heartburn drugs are safe for the foetus. The study, conducted by researchers at the Ben-Gurion University of the Negev, Israel,
A recent Israeli study has shown that the foetus is not adversely affected by heartburn drugs.
The study, conducted by researchers at the Ben-Gurion University of the Negev, Israel, has been published in the Journal of Clinical Pharmacology.
FDA Concludes No Heart Attack Risk from Heartburn Drugs
The US FDA officials said Monday they found no evidence of increased heart risks from popular heartburn drugs Prilosec and Nexium.
The US FDA officials said Monday they found no evidence of increased heart risks from popular heartburn drugs Prilosec and Nexium.
The H2 blockers are the most commonly used medication to relieve acid reflux symptoms of heartburn, regurgitation and trouble swallowing in pregnant women.
Dr. Rafael Gorodischer, professor emeritus at Ben-Gurion University of the Negev said: "Of the vast majority of medications approved for use, there is insufficient data from human studies to determine whether the benefits of therapy exceed the risk to the fetus.
"Medicines are approved for use only after there is sufficient scientific evidence demonstrating the drug safety and effectiveness for its intended uses."
"Exposure to H2 blockers among this group was not associated with significantly increased risks of major congenital malformations. The results were unchanged when therapeutic abortions of exposed fetuses were included in the analysis.
Advertisement
Source-ANI
TAN
